Skip to the page

Data / Drug companies / Cambrex Profarmaco Milano Srl

Cambrex Profarmaco Milano Srl: 43 products in the FDA NDC directory, labeler code 12828

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Cambrex Profarmaco Milano Srl (labeler code 12828) lists 43 products in the FDA National Drug Code Directory. By type: 43 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on August 4, 2022.

The request: Watch Cambrex Profarmaco Milano Srl (FDA labeler code 12828): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
12828
Products in commercial distribution
43
Packages
104
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule IV 17, Schedule V 1
Started marketing in the last 12 months
0
Earliest marketing start
January 21, 1986
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients43100%

Products by type

TypeProductsShare
Bulk ingredients43100%

Dosage forms

Dosage formProductsShare
Powder43100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ambroxol hcl12828-0093PowderBulk ingredientsAugust 4, 2022
Midazolam hcl12828-0092PowderBulk ingredientsOctober 18, 2021
Maraviroc12828-0091PowderBulk ingredientsSeptember 24, 2019
Lormetazepam12828-0021PowderBulk ingredientsDecember 9, 2016
Rifaximin12828-0089PowderBulk ingredientsNovember 9, 2016
Lacosamide12828-0087PowderBulk ingredientsJuly 21, 2016
Clobazam12828-0084PowderBulk ingredientsJuly 21, 2016
Aripiprazole12828-0088PowderBulk ingredientsDecember 1, 2014
Epinephrine bitartrate12828-0083PowderBulk ingredientsJune 3, 2014
Epinephrine12828-0082PowderBulk ingredientsAugust 1, 2012
Zolpidem tartrate12828-0086PowderBulk ingredientsJune 18, 2012
Sodium picosulfate12828-0081PowderBulk ingredientsJanuary 19, 2011
Raloxifene hydrochloride12828-0085PowderBulk ingredientsJanuary 3, 2011
Estazolam12828-0077PowderBulk ingredientsJanuary 28, 2002
Norepinephrine bitartrate12828-0064PowderBulk ingredientsSeptember 7, 2000
Terbutaline sulfate12828-0053PowderBulk ingredientsAugust 21, 1998
Clozapine12828-0072PowderBulk ingredientsDecember 5, 1996
Sotalol hydrochloride12828-0071PowderBulk ingredientsDecember 5, 1996
Labetalol hydrochloride12828-0070PowderBulk ingredientsNovember 11, 1996
Amiodarone hcl12828-0018PowderBulk ingredientsOctober 16, 1996
Midazolam12828-0069PowderBulk ingredientsOctober 3, 1996
Clonazepam12828-0060PowderBulk ingredientsMarch 8, 1996
Amiloride hcl12828-0034PowderBulk ingredientsApril 11, 1995
Cysteamine bitartrate12828-0068PowderBulk ingredientsFebruary 22, 1993
Cromolyn sodium12828-0062PowderBulk ingredientsFebruary 17, 1993

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.